Australia's Incannex Healthcare hits 4-month low on discounted capital raise
04/12/2022 23:43
** Shares of Incannex Healthcare Ltd IHL.AX fall as much
as 13% to A$0.20, their lowest since Aug 3
** Pharmaceutical development co undertakes A$13 mln ($8.83
mln) institutional placement
** Issue price of A$0.205 per share at a discount of 10.9%
to stock's last close
** Co posts biggest intraday pct fall since Nov 21
** Shares down 63.2% YTD, as of last close
($1 = 1.4721 Australian dollars)
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsBrief: Incannex Healthcare Says Computershare To Be Appointed As US Transfer Agent
Brief: Incannex Healthcare Says Federal Court Of Australia Approved Proposed Schemes Of Arrangement Between Incannex And Its Shareholders
Australia's Incannex up as shareholders in favour of US redomicile
Brief: Incannex Healthcare Will Prepare FDA Ind Application PSI-Gad
Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed